National Institutes of Health

October 15, 2019

Mayo researcher secures NIH grant to advance care of rare disease

By Colette Gallagher Colette Gallagher (@colettegallagher)

Eva Morava-Kozicz, M.D., Ph.D. received a $5 million grant from the National Institutes of Health to study frontiers in congenital disorders of glycosylation (CDG). These disorders often cause serious, sometimes fatal, malfunction of several different organ systems in affected infants. “This grant will allow us to leverage cross-disciplinary, team-based clinical science to address decades of unresolved […]

View full entry

Tags: Eva Morava-Kozicz, Mayo Clinic Center for Individualized Medicine, National Institutes of Health, rare disease


July 18, 2019

Targeting therapy to each patient’s unique cancer

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support  for Precision […]

View full entry

Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma


Contact Us · Privacy Policy